Patterns of Pain and Interference in Patients with Painful Bone Metastases: A Brief Pain Inventory Validation Study
Accepted 15 July 2009.
Abstract
Bone metastases are prevalent, painful, and carry a poorer prognosis for pain control compared with other cancer pain syndromes. Standard tools to measure pain have not been validated in this patient population, and particular subgroups with more challenging symptoms have yet to be identified and studied. The objectives of this study were 1) to validate the psychometric properties of the Brief Pain Inventory (BPI) and its Pain and Interference subscales in patients with clinically significant metastatic bone pain requiring palliative radiotherapy and 2) to examine differences in BPI subscales among predefined subgroups of bone metastases patients. A total of 258 patients evaluated and treated through a rapid access radiation therapy clinic between July 2002, and November 2006, were included in the analysis. High internal consistency of the BPI subscales of Pain, Activity interference, and Affect interference was demonstrated by Cronbach's alpha between 0.81 and 0.89. Removing sleep interference improved model fit in confirmatory factor analysis. The BPI revealed an alarming pattern in patients with lower body metastases, who reported substantial interference of activity even though pain levels were mild or moderate. Such patients may require prompt clinical attention to better meet their needs. Finally, the allocation of interference from sleep within the BPI framework, in our population of pain patients, requires further study.
aDepartment of Oncology, Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta, Canada
bDepartment of Clinical Neurosciences, Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta, Canada
cDepartment of Medicine, Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta, Canada
dCancer Pain Clinic, Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta, Canada
eInstitute for Work & Health, Toronto, Ontario, Canada
fSt. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada
gDalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada
Address correspondence to: Jackson S.Y. Wu, MD, Department of Oncology, Tom Baker Cancer Centre, University of Calgary, 1331–29th St NW, Calgary, Alberta T2N 4N2, Canada.
This study was supported in part by the Canadian Institute of Health Research Team grant in Difficult Pain Problems (#PET 69772). Dr. Jackson S.Y. Wu's educational fellowship in clinical epidemiology at the University of Toronto was funded by the Alberta Cancer Board. Dr. Peter M. Smith is supported by a New Investigator Award from the Canadian Institute of Health Research.